These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11218695)

  • 1. Onchocerciasis (river blindness).
    Wkly Epidemiol Rec; 2001 Jan; 76(3):18-22. PubMed ID: 11218695
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling targeted ivermectin treatment for controlling river blindness.
    Poolman EM; Galvani AP
    Am J Trop Med Hyg; 2006 Nov; 75(5):921-7. PubMed ID: 17123988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onchocerciasis (river blindness). Report from the eighth InterAmerican conference on onchocerciasis, Caracas, Venezuela.
    Wkly Epidemiol Rec; 1999 Nov; 74(45):377-80. PubMed ID: 10985161
    [No Abstract]   [Full Text] [Related]  

  • 5. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
    Cupp EW; Sauerbrey M; Richards F
    Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Onchocerciasis Elimination Program for the Americas (OEPA).
    Sauerbrey M
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful elimination of onchocerciasis (river blindness) vectors from isolated foci in two African countries.
    Brattig NW
    Acta Trop; 2009 Sep; 111(3):201-2. PubMed ID: 19619685
    [No Abstract]   [Full Text] [Related]  

  • 8. Onchocerciasis (river blindness). Report from the twelfth InterAmerican Conference on Onchocerciasis, Manaus, Brazil.
    Wkly Epidemiol Rec; 2003 Oct; 78(41):361-4. PubMed ID: 14997698
    [No Abstract]   [Full Text] [Related]  

  • 9. Onchocerciasis (river blindness). Report from the thirteenth InterAmerican Conference on Onchocerciasis, Cartagena de Indias, Colombia.
    Wkly Epidemiol Rec; 2004 Aug; 79(34):310-2. PubMed ID: 15460014
    [No Abstract]   [Full Text] [Related]  

  • 10. Onchocerciasis (river blindness).
    Wkly Epidemiol Rec; 2001 Jul; 76(27):205-10. PubMed ID: 11475871
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
    Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
    Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Onchocerciasis as a health problem in the southeastern Mexico].
    Rivas Alcalá A; Schlie Guzmán A
    Bol Chil Parasitol; 1987; 42(3-4):58-63. PubMed ID: 3504155
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis.
    Abanobi OC; Chukwuocha UM; Onwuiiliri CO; Opara KC
    East Afr J Public Health; 2011 Mar; 8(1):33-7. PubMed ID: 22066280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Knowledge, attitudes and practices of the population of SAMBWA health area in relation to the treatment of onchocerciasis with ivermectin under community directives].
    Philippe CM; Bienvenu YA; Francoise MK; Eric MS; Abdon MW; Luboya ON
    Pan Afr Med J; 2014; 19():356. PubMed ID: 25932069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The onchocerciasis chronicle: from the beginning to the end?
    Crump A; Morel CM; Omura S
    Trends Parasitol; 2012 Jul; 28(7):280-8. PubMed ID: 22633470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The life and times of ivermectin - a success story.
    Omura S; Crump A
    Nat Rev Microbiol; 2004 Dec; 2(12):984-9. PubMed ID: 15550944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onchocerciasis presenting with lower extremity, hypopigmented macules.
    Vernick W; Turner SE; Burov E; Telang GH
    Cutis; 2000 May; 65(5):293-7. PubMed ID: 10826090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ivermectin in the treatment of onchocerciasis: feasibility, compliance and efficacy of a mass treatment].
    Awissi D; Heuschkel C; Banla M; Schulz-Key H
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):739-49. PubMed ID: 1819423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular approaches to the control of onchocerciasis in Mexico].
    Rodríguez-Pérez MA
    Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.